首页> 美国卫生研究院文献>Central European Journal of Urology >A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib
【2h】

A case of metastatic renal cell carcinoma treated effectively by gemcitabine and sunitinib

机译:吉西他滨联合舒尼替尼治疗转移性肾细胞癌1例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A 60-year-old man with renal cell carcinoma developed lung metastases after treatment with left radical nephrectomy (pT3bN0M0, clear cell renal carcinoma, Fuhrman G3 >2). The patient received treatment with gemcitabine and interferon-α and achieved complete response after seven cycles of therapy. However, eight months later, local recurrence was discovered in the renal fossa. We changed the therapeutic strategy to sunitinib, a multi-target tyrosine kinase inhibitor. The patient achieved a complete response after twelve cycles of therapy. This case report illustrates the effective use of gemcitabine and sunitinib sequentially for a patient with metastatic renal cell carcinoma.
机译:一名患有肾细胞癌的60岁男性在接受左根切除术(pT3bN0M0,透明细胞肾癌,Fuhrman G3> 2)治疗后出现了肺转移。该患者接受了吉西他滨和干扰素-α的治疗,并在七个治疗周期后完全缓解。但是,八个月后,在肾窝中发现了局部复发。我们将治疗策略改为多目标酪氨酸激酶抑制剂舒尼替尼。在十二个疗程后,患者获得了完全缓解。该病例报告说明吉西他滨和舒尼替尼依次有效用于转移性肾细胞癌患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号